1. Sage PT, Tan CL, Freeman GJ, Haigis M, Sharpe AH. Defective TFH Cell Function and Increased TFR Cells Contribute to Defective Antibody Production in Aging. Cell reports. 2015; 12(2):163-71. NIHMSID: NIHMS699135 PubMed [journal] PMID: 26146074, PMCID: PMC4504745 2. Sage PT, Sharpe AH. T follicular regulatory cells in the regulation of B cell responses. Trends in immunology. 2015; 36(7):410-8. NIHMSID: NIHMS705013 PubMed [journal] PMID: 26091728, PMCID: PMC4508020 3. Pauken KE, Nelson CE, Martinov T, Spanier JA, Heffernan JR, et al. Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade. Journal of immunology (Baltimore, Md. : 1950). 2015; 194(8):3551-5. NIHMSID: NIHMS666620 PubMed [journal] PMID: 25769925, PMCID: PMC4390507 4. Mahoney KM, Freeman GJ, McDermott DF. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Clinical therapeutics. 2015; 37(4):764-82. NIHMSID: NIHMS677977 PubMed [journal] PMID: 25823918, PMCID: PMC4497957 5. Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, et al. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nature communications. 2015; 6:6692. PubMed [journal] PMID: 25809635, PMCID: PMC4389235 6. McDonald-Hyman C, Turka LA, Blazar BR. Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Science translational medicine. 2015; 7(280):280rv2. NIHMSID: NIHMS687166 PubMed [journal] PMID: 25810312, PMCID: PMC4425354 7. Maazi H, Patel N, Sankaranarayanan I, Suzuki Y, Rigas D, et al. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity. 2015; 42(3):538-51. NIHMSID: NIHMS667453 PubMed [journal] PMID: 25769613, PMCID: PMC4366271 8. Parmar S, Liu X, Najjar A, Shah N, Yang H, et al. Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo. Blood. 2015; 125(9):1502-6. PubMed [journal] PMID: 25428215, PMCID: PMC4342362 9. Li Y, Chen HL, Bannick N, Henry M, Holm AN, et al. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. Journal of immunology (Baltimore, Md. : 1950). 2015; 194(3):1011-20. NIHMSID: NIHMS644178 PubMed [journal] PMID: 25527786, PMCID: PMC4297687 10. Sarantopoulos S, Blazar BR, Cutler C, Ritz J. Reprint of: B cells in chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015; 21(2 Suppl):S11-8. PubMed [journal] PMID: 25620647 11. Schildberg FA, Sharpe AH, Turley SJ. Hepatic immune regulation by stromal cells. Current opinion in immunology. 2015; 32:1-6. PubMed [journal] PMID: 25463592 12. Huynh A, DuPage M, Priyadharshini B, Sage PT, Quiros J, et al. Control of PI(3) kinase in Treg cells maintains homeostasis and lineage stability. Nature immunology. 2015; 16(2):188-96. NIHMSID: NIHMS646214 PubMed [journal] PMID: 25559257, PMCID: PMC4297515 13. Zhu C, Sakuishi K, Xiao S, Sun Z, Zaghouani S, et al. An IL-27/NFIL3 signalling axis drives Tim-3 and IL-10 expression and T-cell dysfunction. Nature communications. 2015; 6:6072. NIHMSID: NIHMS648243 PubMed [journal] PMID: 25614966, PMCID: PMC4311884 14. Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, et al. CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature. 2015; 517(7534):386-90. NIHMSID: NIHMS644082 PubMed [journal] PMID: 25363763, PMCID: PMC4297519 15. Hechinger AK, Smith BA, Flynn R, Hanke K, McDonald-Hyman C, et al. Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD. Blood. 2015; 125(3):570-80. PubMed [journal] PMID: 25352130, PMCID: PMC4296017 16. Godec J, Cowley GS, Barnitz RA, Root DE, Sharpe AH, et al. Inducible RNAi in vivo reveals that the transcription factor BATF is required to initiate but not maintain CD8+ T-cell effector differentiation. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112(2):512-7. PubMed [journal] PMID: 25548173, PMCID: PMC4299213 17. Tuladhar R, Oghumu S, Dong R, Peterson A, Sharpe AH, et al. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major. Experimental parasitology. 2015; 148:49-55. NIHMSID: NIHMS697175 PubMed [journal] PMID: 25447125, PMCID: PMC4474147 18. Ron-Harel N, Sharpe AH, Haigis MC. Mitochondrial metabolism in T cell activation and senescence: a mini-review. Gerontology. 2015; 61(2):131-8. PubMed [journal] PMID: 25402204 19. Sage PT, Paterson AM, Lovitch SB, Sharpe AH. The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. Immunity. 2014; 41(6):1026-39. NIHMSID: NIHMS647303 PubMed [journal] PMID: 25526313, PMCID: PMC4309019 20. Singh K, Stempora L, Harvey RD, Kirk AD, Larsen CP, et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2014; 14(12):2691-703. NIHMSID: NIHMS615760 PubMed [journal] PMID: 25359003, PMCID: PMC4236286 21. Sage PT, Alvarez D, Godec J, von Andrian UH, Sharpe AH. Circulating T follicular regulatory and helper cells have memory-like properties. The Journal of clinical investigation. 2014; 124(12):5191-204. PubMed [journal] PMID: 25347469, PMCID: PMC4348955 22. Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature. 2014; 515(7528):577-81. NIHMSID: NIHMS637450 PubMed [journal] PMID: 25428507, PMCID: PMC4279952 23. Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, Chen W, Scher JU, et al. Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism. Proceedings of the National Academy of Sciences of the United States of America. 2014; 111(47):16814-9. PubMed [journal] PMID: 25385601, PMCID: PMC4250132 24. Herrera AF, Kim HT, Bindra B, Jones KT, Alyea EP 3rd, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014; 20(11):1737-43. NIHMSID: NIHMS625181 PubMed [journal] PMID: 25017765, PMCID: PMC4465759 25. Dubovsky JA, Flynn R, Du J, Harrington BK, Zhong Y, et al. Ibrutinib treatment ameliorates murine chronic graft-versus-host disease. The Journal of clinical investigation. 2014; 124(11):4867-76. PubMed [journal] PMID: 25271622, PMCID: PMC4347242 26. Matta BM, Lott JM, Mathews LR, Liu Q, Rosborough BR, et al. IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. Journal of immunology (Baltimore, Md. : 1950). 2014; 193(8):4010-20. NIHMSID: NIHMS620669 PubMed [journal] PMID: 25217167, PMCID: PMC4185240 27. Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, et al. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease. The Journal of clinical investigation. 2014; 124(10):4266-80. PubMed [journal] PMID: 25157821, PMCID: PMC4191032 28. Wolf AI, Strauman MC, Mozdzanowska K, Whittle JR, Williams KL, et al. Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus. Journal of virology. 2014; 88(20):11995-2005. PubMed [journal] PMID: 25100838, PMCID: PMC4178749 29. Ganguly S, Ross DB, Panoskaltsis-Mortari A, Kanakry CG, Blazar BR, et al. Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood. 2014; 124(13):2131-41. PubMed [journal] PMID: 25139358, PMCID: PMC4186542 30. Pai CC, Chen M, Mirsoian A, Grossenbacher SK, Tellez J, et al. Treatment of chronic graft-versus-host disease with bortezomib. Blood. 2014; 124(10):1677-88. PubMed [journal] PMID: 25009225, PMCID: PMC4155274 31. Murase K, Kim HT, Bascug OR, Kawano Y, Ryan J, et al. Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation. Haematologica. 2014; 99(9):1499-508. PubMed [journal] PMID: 24859877, PMCID: PMC4562540 32. Penaloza-MacMaster P, Kamphorst AO, Wieland A, Araki K, Iyer SS, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. The Journal of experimental medicine. 2014; 211(9):1905-18. PubMed [journal] PMID: 25113973, PMCID: PMC4144726 33. Wu C, Thalhamer T, Franca RF, Xiao S, Wang C, et al. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity. 2014; 41(2):270-82. NIHMSID: NIHMS611280 PubMed [journal] PMID: 25065622, PMCID: PMC4219323 34. Ding ZC, Lu X, Yu M, Lemos H, Huang L, et al. Immunosuppressive myeloid cells induced by chemotherapy attenuate antitumor CD4+ T-cell responses through the PD-1-PD-L1 axis. Cancer research. 2014; 74(13):3441-53. NIHMSID: NIHMS591072 PubMed [journal] PMID: 24780756, PMCID: PMC4079842 35. Cooper ZA, Juneja VR, Sage PT, Frederick DT, Piris A, et al. Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade. Cancer immunology research. 2014; 2(7):643-54. NIHMSID: NIHMS592049 PubMed [journal] PMID: 24903021, PMCID: PMC4097121 36. Flynn R, Du J, Veenstra RG, Reichenbach DK, Panoskaltsis-Mortari A, et al. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. Blood. 2014; 123(25):3988-98. PubMed [journal] PMID: 24820310, PMCID: PMC4064335 37. Xiao Y, Yu S, Zhu B, Bedoret D, Bu X, et al. RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance. The Journal of experimental medicine. 2014; 211(5):943-59. PubMed [journal] PMID: 24752301, PMCID: PMC4010901 38. Jacobson CA, Sun L, Kim HT, McDonough SM, Reynolds CG, et al. Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014; 20(5):668-75. NIHMSID: NIHMS560589 PubMed [journal] PMID: 24462743, PMCID: PMC3985384 39. Joller N, Lozano E, Burkett PR, Patel B, Xiao S, et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity. 2014; 40(4):569-81. NIHMSID: NIHMS582401 PubMed [journal] PMID: 24745333, PMCID: PMC4070748 40. MacDonald KP, Le Texier L, Zhang P, Morris H, Kuns RD, et al. Modification of T cell responses by stem cell mobilization requires direct signaling of the T cell by G-CSF and IL-10. Journal of immunology (Baltimore, Md. : 1950). 2014; 192(7):3180-9. NIHMSID: NIHMS579676 PubMed [journal] PMID: 24585878, PMCID: PMC4018243 41. Lin KL, Fulton LM, Berginski M, West ML, Taylor NA, et al. Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD. Blood. 2014; 123(10):1604-14. PubMed [journal] PMID: 24415540, PMCID: PMC3945868 42. Sawitzki B, Brunstein C, Meisel C, Schumann J, Vogt K, et al. Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014; 20(2):173-82. NIHMSID: NIHMS537455 PubMed [journal] PMID: 24184334, PMCID: PMC3946612 43. Chiang HS, Zhao Y, Song JH, Liu S, Wang N, et al. GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses. Nature immunology. 2014; 15(1):63-71. NIHMSID: NIHMS598207 PubMed [journal] PMID: 24270516, PMCID: PMC4066330 44. Mott KR, Allen SJ, Zandian M, Akbari O, Hamrah P, et al. Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses. PloS one. 2014; 9(1):e87617. PubMed [journal] PMID: 24475315, PMCID: PMC3903765 45. Horne-Debets JM, Faleiro R, Karunarathne DS, Liu XQ, Lineburg KE, et al. PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria. Cell reports. 2013; 5(5):1204-13. PubMed [journal] PMID: 24316071 46. Mukherjee G, Geliebter A, Babad J, Santamaria P, Serreze DV, et al. DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1. International immunology. 2013; 25(11):651-60. PubMed [journal] PMID: 24021877, PMCID: PMC3806169 47. Saha A, Aoyama K, Taylor PA, Koehn BH, Veenstra RG, et al. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. Blood. 2013; 122(17):3062-73. PubMed [journal] PMID: 24030385, PMCID: PMC3811178 48. Cooper ZA, Frederick DT, Juneja VR, Sullivan RJ, Lawrence DP, et al. BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology. 2013; 2(10):e26615. PubMed [journal] PMID: 24251082, PMCID: PMC3827093 49. Vander Lugt B, Tubo NJ, Nizza ST, Boes M, Malissen B, et al. CCR7 plays no appreciable role in trafficking of central memory CD4 T cells to lymph nodes. Journal of immunology (Baltimore, Md. : 1950). 2013; 191(6):3119-27. NIHMSID: NIHMS509474 PubMed [journal] PMID: 23935190, PMCID: PMC3784989 50. Fuller MJ, Callendret B, Zhu B, Freeman GJ, Hasselschwert DL, et al. Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(37):15001-6. PubMed [journal] PMID: 23980172, PMCID: PMC3773803 51. Kamphorst AO, Ahmed R. CD4 T-cell immunotherapy for chronic viral infections and cancer. Immunotherapy. 2013; 5(9):975-87. NIHMSID: NIHMS531050 PubMed [journal] PMID: 23998732, PMCID: PMC3864579 52. Chen BJ, Chapuy B, Ouyang J, Sun HH, Roemer MG, et al. PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013; 19(13):3462-73. NIHMSID: NIHMS597127 PubMed [journal] PMID: 23674495, PMCID: PMC4102335 53. Jones JC, Freeman GJ. Costimulatory genes: hotspots of conflict between host defense and autoimmunity. Immunity. 2013; 38(6):1083-5. NIHMSID: NIHMS497775 PubMed [journal] PMID: 23809156, PMCID: PMC3773510 54. Duraiswamy J, Kaluza KM, Freeman GJ, Coukos G. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer research. 2013; 73(12):3591-603. NIHMSID: NIHMS473353 PubMed [journal] PMID: 23633484, PMCID: PMC3686913 55. Laurent G, German NJ, Saha AK, de Boer VC, Davies M, et al. SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Molecular cell. 2013; 50(5):686-98. NIHMSID: NIHMS482213 PubMed [journal] PMID: 23746352, PMCID: PMC3721068 56. Riella LV, Dada S, Chabtini L, Smith B, Huang L, et al. B7h (ICOS-L) maintains tolerance at the fetomaternal interface. The American journal of pathology. 2013; 182(6):2204-13. PubMed [journal] PMID: 23578385, PMCID: PMC3668017 57. West EE, Jin HT, Rasheed AU, Penaloza-Macmaster P, Ha SJ, et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. The Journal of clinical investigation. 2013; 123(6):2604-15. PubMed [journal] PMID: 23676462, PMCID: PMC3668811 58. Kamphorst AO, Ahmed R. Manipulating the PD-1 pathway to improve immunity. Current opinion in immunology. 2013; 25(3):381-8. PubMed [journal] PMID: 23582509 59. Sharma MD, Huang L, Choi JH, Lee EJ, Wilson JM, et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity. 2013; 38(5):998-1012. NIHMSID: NIHMS472957 PubMed [journal] PMID: 23684987, PMCID: PMC3681093 60. Nikiforow S, Kim HT, Bindra B, McDonough S, Glotzbecker B, et al. Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013; 19(5):804-11. NIHMSID: NIHMS462487 PubMed [journal] PMID: 23416855, PMCID: PMC3642980 61. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature. 2013; 496(7446):513-7. NIHMSID: NIHMS443495 PubMed [journal] PMID: 23467085, PMCID: PMC3637879 62. Matsuoka K, Koreth J, Kim HT, Bascug G, McDonough S, et al. Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease. Science translational medicine. 2013; 5(179):179ra43. NIHMSID: NIHMS473383 PubMed [journal] PMID: 23552371, PMCID: PMC3686517 63. Cubas RA, Mudd JC, Savoye AL, Perreau M, van Grevenynghe J, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nature medicine. 2013; 19(4):494-9. NIHMSID: NIHMS517810 PubMed [journal] PMID: 23475201, PMCID: PMC3843317 64. Ichinose K, Zhang Z, Koga T, Juang YT, Kis-Tóth K, et al. Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice. Arthritis and rheumatism. 2013; 65(3):764-9. NIHMSID: NIHMS419476 PubMed [journal] PMID: 23203389, PMCID: PMC3582760 65. Oghumu S, Dong R, Varikuti S, Shawler T, Kampfrath T, et al. Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse. Journal of immunology (Baltimore, Md. : 1950). 2013; 190(5):2229-40. NIHMSID: NIHMS469220 PubMed [journal] PMID: 23338236, PMCID: PMC3683850 66. Shay T, Jojic V, Zuk O, Rothamel K, Puyraimond-Zemmour D, et al. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(8):2946-51. PubMed [journal] PMID: 23382184, PMCID: PMC3581886 67. Naito M, Hainz U, Burkhardt UE, Fu B, Ahove D, et al. CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells. Cancer immunology, immunotherapy : CII. 2013; 62(2):347-57. PubMed [journal] PMID: 22926059, PMCID: PMC3569584 68. Sage PT, Francisco LM, Carman CV, Sharpe AH. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nature immunology. 2013; 14(2):152-61. NIHMSID: NIHMS515427 PubMed [journal] PMID: 23242415, PMCID: PMC3788614 69. Chang SY, Song JH, Guleng B, Cotoner CA, Arihiro S, et al. Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation. Immunity. 2013; 38(1):153-65. NIHMSID: NIHMS428821 PubMed [journal] PMID: 23246312, PMCID: PMC3858856 70. Maazi H, Singh AK, Speak AO, Lombardi V, Lam J, et al. Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. PloS one. 2013; 8(3):e59599. PubMed [journal] PMID: 23555047, PMCID: PMC3598698 71. El-Far M, Isabelle C, Chomont N, Bourbonnière M, Fonseca S, et al. Down-regulation of CTLA-4 by HIV-1 Nef protein. PloS one. 2013; 8(1):e54295. PubMed [journal] PMID: 23372701, PMCID: PMC3553160 72. D'Addio F, Ueno T, Clarkson M, Zhu B, Vergani A, et al. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival. PloS one. 2013; 8(4):e60391. PubMed [journal] PMID: 23593209, PMCID: PMC3617215 73. Encyclopedia of Cancer Therapeutic Targets Freeman GJ, Sharpe AH. , editor. New York: Springer; 2013. PD-1. My Bibliography [book] 74. Paley MA, Kroy DC, Odorizzi PM, Johnnidis JB, Dolfi DV, et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science (New York, N.Y.). 2012; 338(6111):1220-5. NIHMSID: NIHMS464570 PubMed [journal] PMID: 23197535, PMCID: PMC3653769 75. Chou CK, Schietinger A, Liggitt HD, Tan X, Funk S, et al. Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer. Journal of immunology (Baltimore, Md. : 1950). 2012; 189(8):3936-46. NIHMSID: NIHMS401773 PubMed [journal] PMID: 22984076, PMCID: PMC3466379 76. Riella LV, Paterson AM, Sharpe AH, Chandraker A. Role of the PD-1 pathway in the immune response. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2012; 12(10):2575-87. NIHMSID: NIHMS516261 PubMed [journal] PMID: 22900886, PMCID: PMC3784243 77. Koreth J, Stevenson KE, Kim HT, McDonough SM, Bindra B, et al. Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012; 30(26):3202-8. PubMed [journal] PMID: 22869883, PMCID: PMC3434979 78. Ueno T, Yeung MY, McGrath M, Yang S, Zaman N, et al. Intact B7-H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses. European journal of immunology. 2012; 42(9):2343-53. NIHMSID: NIHMS512629 PubMed [journal] PMID: 22733595, PMCID: PMC3822046 79. Sham CW, Chan AM, Kwong JM, Caprioli J, Nusinowitz S, et al. Neuronal programmed cell death-1 ligand expression regulates retinal ganglion cell number in neonatal and adult mice. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2012; 32(3):227-37. NIHMSID: NIHMS522912 PubMed [journal] PMID: 22635166, PMCID: PMC3839320 80. Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity. 2012; 37(2):339-50. NIHMSID: NIHMS401167 PubMed [journal] PMID: 22921121, PMCID: PMC3477611 81. Fulton LM, Carlson MJ, Coghill JM, Ott LE, West ML, et al. Attenuation of acute graft-versus-host disease in the absence of the transcription factor RORγt. Journal of immunology (Baltimore, Md. : 1950). 2012; 189(4):1765-72. NIHMSID: NIHMS386147 PubMed [journal] PMID: 22778391, PMCID: PMC3411855 82. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, et al. IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. Journal of immunology (Baltimore, Md. : 1950). 2012; 189(4):2033-42. NIHMSID: NIHMS384261 PubMed [journal] PMID: 22778394, PMCID: PMC3509544 83. Veenstra RG, Taylor PA, Zhou Q, Panoskaltsis-Mortari A, Hirashima M, et al. Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells. Blood. 2012; 120(3):682-90. PubMed [journal] PMID: 22677125, PMCID: PMC3401220 84. Kean LS, Blazar BR. Cooking up tolerance: has a new recipe been created? American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2012; 12(7):1667-9. NIHMSID: NIHMS413698 PubMed [journal] PMID: 22702487, PMCID: PMC3482492 85. Silberman D, Bucknum A, Bartlett T, Composto G, Kozlowski M, et al. CD28 ligation increases macrophage suppression of T-cell proliferation. Cellular & molecular immunology. 2012; 9(4):341-9. NIHMSID: NIHMS367693 PubMed [journal] PMID: 22522653, PMCID: PMC3389597 86. Hirahara K, Ghoreschi K, Yang XP, Takahashi H, Laurence A, et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. Immunity. 2012; 36(6):1017-30. NIHMSID: NIHMS383411 PubMed [journal] PMID: 22726954, PMCID: PMC3785111 87. Tarrio ML, Grabie N, Bu DX, Sharpe AH, Lichtman AH. PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis. Journal of immunology (Baltimore, Md. : 1950). 2012; 188(10):4876-84. NIHMSID: NIHMS363173 PubMed [journal] PMID: 22491251, PMCID: PMC3345066 88. Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. Nature reviews. Immunology. 2012; 12(6):443-58. NIHMSID: NIHMS434473 PubMed [journal] PMID: 22576252, PMCID: PMC3552454 89. Good-Jacobson KL, Song E, Anderson S, Sharpe AH, Shlomchik MJ. CD80 expression on B cells regulates murine T follicular helper development, germinal center B cell survival, and plasma cell generation. Journal of immunology (Baltimore, Md. : 1950). 2012; 188(9):4217-25. NIHMSID: NIHMS361301 PubMed [journal] PMID: 22450810, PMCID: PMC3331930 90. Sage PT, Varghese LM, Martinelli R, Sciuto TE, Kamei M, et al. Antigen recognition is facilitated by invadosome-like protrusions formed by memory/effector T cells. Journal of immunology (Baltimore, Md. : 1950). 2012; 188(8):3686-99. NIHMSID: NIHMS358267 PubMed [journal] PMID: 22442443, PMCID: PMC3324627 91. Vijayanand P, Seumois G, Simpson LJ, Abdul-Wajid S, Baumjohann D, et al. Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V. Immunity. 2012; 36(2):175-87. NIHMSID: NIHMS353372 PubMed [journal] PMID: 22326582, PMCID: PMC3288297 92. Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, et al. Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell. 2012; 148(4):739-51. NIHMSID: NIHMS355378 PubMed [journal] PMID: 22341446, PMCID: PMC3313622 93. Ioannou M, Alissafi T, Lazaridis I, Deraos G, Matsoukas J, et al. Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease. Journal of immunology (Baltimore, Md. : 1950). 2012; 188(3):1136-46. PubMed [journal] PMID: 22210912 94. Freeman GJ, Sharpe AH. A new therapeutic strategy for malaria: targeting T cell exhaustion. Nature immunology. 2012; 13(2):113-5. NIHMSID: NIHMS481368 PubMed [journal] PMID: 22261959, PMCID: PMC3690321 95. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation Socie G, Blazar BR. 1st ed. , editors. London: Elsevier; 2012. Overview of the Immune Biology of Allogeneic HSCT; p.1-17. My Bibliography [book] 96. Liu SM, Sutherland AP, Zhang Z, Rainbow DB, Quintana FJ, et al. Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity. Journal of immunology (Baltimore, Md. : 1950). 2012; 188(1):155-62. NIHMSID: NIHMS336771 PubMed [journal] PMID: 22124121, PMCID: PMC3245861 97. Butte MJ, Lee SJ, Jesneck J, Keir ME, Haining WN, et al. CD28 costimulation regulates genome-wide effects on alternative splicing. PloS one. 2012; 7(6):e40032. PubMed [journal] PMID: 22768209, PMCID: PMC3386953 98. Aubert RD, Kamphorst AO, Sarkar S, Vezys V, Ha SJ, et al. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(52):21182-7. PubMed [journal] PMID: 22160724, PMCID: PMC3248546 99. Hippen KL, Riley JL, June CH, Blazar BR. Clinical perspectives for regulatory T cells in transplantation tolerance. Seminars in immunology. 2011; 23(6):462-8. NIHMSID: NIHMS316601 PubMed [journal] PMID: 21820917, PMCID: PMC3230779 100. Pot C, Apetoh L, Awasthi A, Kuchroo VK. Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Seminars in immunology. 2011; 23(6):438-45. NIHMSID: NIHMS318641 PubMed [journal] PMID: 21893418, PMCID: PMC3230686 101. Shainheit MG, Lasocki KW, Finger E, Larkin BM, Smith PM, et al. The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1β. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(10):5328-35. NIHMSID: NIHMS325454 PubMed [journal] PMID: 22003203, PMCID: PMC3653625 102. Baban B, Chandler PR, Johnson BA 3rd, Huang L, Li M, et al. Physiologic control of IDO competence in splenic dendritic cells. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(5):2329-35. NIHMSID: NIHMS307739 PubMed [journal] PMID: 21813777, PMCID: PMC3556270 103. Vezys V, Penaloza-MacMaster P, Barber DL, Ha SJ, Konieczny B, et al. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(4):1634-42. NIHMSID: NIHMS518946 PubMed [journal] PMID: 21742975, PMCID: PMC4404506 104. Yang J, Riella LV, Chock S, Liu T, Zhao X, et al. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(3):1113-9. NIHMSID: NIHMS298997 PubMed [journal] PMID: 21697455, PMCID: PMC3140607 105. Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends in immunology. 2011; 32(8):345-9. NIHMSID: NIHMS306998 PubMed [journal] PMID: 21697013, PMCID: PMC3164311 106. Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, et al. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(3):1097-105. NIHMSID: NIHMS296832 PubMed [journal] PMID: 21697456, PMCID: PMC3148082 107. Koh AE, Njoroge SW, Feliu M, Cook A, Selig MK, et al. The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis. Journal of autoimmunity. 2011; 37(1):48-57. NIHMSID: NIHMS287812 PubMed [journal] PMID: 21561736, PMCID: PMC3110600 108. Brown DR, Calpe S, Keszei M, Wang N, McArdel S, et al. Cutting edge: an NK cell-independent role for Slamf4 in controlling humoral autoimmunity. Journal of immunology (Baltimore, Md. : 1950). 2011; 187(1):21-5. NIHMSID: NIHMS293038 PubMed [journal] PMID: 21622868, PMCID: PMC3119727 109. Mfarrej B, Keir M, Dada S, Trikudanathan S, Sayegh MH, et al. Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditis. Clinical immunology (Orlando, Fla.). 2011; 140(1):47-53. NIHMSID: NIHMS491330 PubMed [journal] PMID: 21498129, PMCID: PMC3730534 110. Hippen KL, Merkel SC, Schirm DK, Nelson C, Tennis NC, et al. Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011; 11(6):1148-57. NIHMSID: NIHMS348771 PubMed [journal] PMID: 21564534, PMCID: PMC3552455 111. Pot C, Apetoh L, Kuchroo VK. Type 1 regulatory T cells (Tr1) in autoimmunity. Seminars in immunology. 2011; 23(3):202-8. NIHMSID: NIHMS313617 PubMed [journal] PMID: 21840222, PMCID: PMC3178065 112. Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, et al. Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity. Science translational medicine. 2011; 3(83):83ra41. NIHMSID: NIHMS348772 PubMed [journal] PMID: 21593401, PMCID: PMC3551476 113. Bu DX, Tarrio M, Maganto-Garcia E, Stavrakis G, Tajima G, et al. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. Arteriosclerosis, thrombosis, and vascular biology. 2011; 31(5):1100-7. NIHMSID: NIHMS285515 PubMed [journal] PMID: 21393583, PMCID: PMC3104026 114. Allen SJ, Hamrah P, Gate D, Mott KR, Mantopoulos D, et al. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. Journal of virology. 2011; 85(9):4184-97. PubMed [journal] PMID: 21307196, PMCID: PMC3126262 115. Riella LV, Watanabe T, Sage PT, Yang J, Yeung M, et al. Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011; 11(4):832-40. PubMed [journal] PMID: 21401869 116. Jin Y, Chauhan SK, El Annan J, Sage PT, Sharpe AH, et al. A novel function for programmed death ligand-1 regulation of angiogenesis. The American journal of pathology. 2011; 178(4):1922-9. PubMed [journal] PMID: 21435468, PMCID: PMC3078456 117. Joller N, Hafler JP, Brynedal B, Kassam N, Spoerl S, et al. Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. Journal of immunology (Baltimore, Md. : 1950). 2011; 186(3):1338-42. NIHMSID: NIHMS292247 PubMed [journal] PMID: 21199897, PMCID: PMC3128994 118. Keszei M, Latchman YE, Vanguri VK, Brown DR, Detre C, et al. Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice. International immunology. 2011; 23(2):149-58. PubMed [journal] PMID: 21278219, PMCID: PMC3107444 119. Barber DL, Mayer-Barber KD, Feng CG, Sharpe AH, Sher A. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. Journal of immunology (Baltimore, Md. : 1950). 2011; 186(3):1598-607. NIHMSID: NIHMS596377 PubMed [journal] PMID: 21172867, PMCID: PMC4059388 120. Jin HT, Ahmed R, Okazaki T. Role of PD-1 in regulating T-cell immunity. Current topics in microbiology and immunology. 2011; 350:17-37. PubMed [journal] PMID: 21061197 121. Zhou Q, Munger ME, Highfill SL, Tolar J, Weigel BJ, et al. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood. 2010; 116(14):2484-93. PubMed [journal] PMID: 20570856, PMCID: PMC2953885 122. El Annan J, Goyal S, Zhang Q, Freeman GJ, Sharpe AH, et al. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. Investigative ophthalmology & visual science. 2010; 51(7):3418-23. PubMed [journal] PMID: 20019373, PMCID: PMC3979489 123. Mueller SN, Vanguri VK, Ha SJ, West EE, Keir ME, et al. PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice. The Journal of clinical investigation. 2010; 120(7):2508-15. PubMed [journal] PMID: 20551512, PMCID: PMC2898584 124. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunological reviews. 2010; 236:219-42. NIHMSID: NIHMS212450 PubMed [journal] PMID: 20636820, PMCID: PMC2919275 125. Good-Jacobson KL, Szumilas CG, Chen L, Sharpe AH, Tomayko MM, et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nature immunology. 2010; 11(6):535-42. NIHMSID: NIHMS195696 PubMed [journal] PMID: 20453843, PMCID: PMC2874069 126. Brown KE, Freeman GJ, Wherry EJ, Sharpe AH. Role of PD-1 in regulating acute infections. Current opinion in immunology. 2010; 22(3):397-401. NIHMSID: NIHMS200588 PubMed [journal] PMID: 20427170, PMCID: PMC2905659 127. Paterson AM, Sharpe AH. Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells. Nature immunology. 2010; 11(2):109-11. NIHMSID: NIHMS390915 PubMed [journal] PMID: 20084066, PMCID: PMC3742103 128. Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal immunology. 2010; 3(1):81-91. NIHMSID: NIHMS181861 PubMed [journal] PMID: 19741598, PMCID: PMC2845714 129. Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. The Journal of experimental medicine. 2009; 206(13):3015-29. PubMed [journal] PMID: 20008522, PMCID: PMC2806460 130. Ruffner MA, Kim SH, Bianco NR, Francisco LM, Sharpe AH, et al. B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function. European journal of immunology. 2009; 39(11):3084-90. NIHMSID: NIHMS251703 PubMed [journal] PMID: 19757438, PMCID: PMC3075967 131. Araki M, Chung D, Liu S, Rainbow DB, Chamberlain G, et al. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. Journal of immunology (Baltimore, Md. : 1950). 2009; 183(8):5146-57. NIHMSID: UKMS27659 PubMed [journal] PMID: 19783679, PMCID: PMC2871291 132. Chen L, Sham CW, Chan AM, Francisco LM, Wu Y, et al. Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells. Investigative ophthalmology & visual science. 2009; 50(10):4941-8. NIHMSID: NIHMS305857 PubMed [journal] PMID: 19420345, PMCID: PMC3222380 133. Pot C, Jin H, Awasthi A, Liu SM, Lai CY, et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. Journal of immunology (Baltimore, Md. : 1950). 2009; 183(2):797-801. NIHMSID: NIHMS142396 PubMed [journal] PMID: 19570826, PMCID: PMC2768608 134. Paterson AM, Vanguri VK, Sharpe AH. SnapShot: B7/CD28 costimulation. Cell. 2009; 137(5):974-4.e1. PubMed [journal] PMID: 19490900 135. Sharpe AH. Mechanisms of costimulation. Immunological reviews. 2009; 229(1):5-11. NIHMSID: NIHMS225857 PubMed [journal] PMID: 19426211, PMCID: PMC2928676 136. Rodriguez-Manzanet R, DeKruyff R, Kuchroo VK, Umetsu DT. The costimulatory role of TIM molecules. Immunological reviews. 2009; 229(1):259-70. NIHMSID: NIHMS329970 PubMed [journal] PMID: 19426227, PMCID: PMC3217781 137. Crawford A, Wherry EJ. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Current opinion in immunology. 2009; 21(2):179-86. NIHMSID: NIHMS117068 PubMed [journal] PMID: 19264470, PMCID: PMC2720162 138. Verhagen J, Gabrysová L, Minaee S, Sabatos CA, Anderson G, et al. Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(9):3306-11. PubMed [journal] PMID: 19218450, PMCID: PMC2642665 139. Reynoso ED, Elpek KG, Francisco L, Bronson R, Bellemare-Pelletier A, et al. Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade. Journal of immunology (Baltimore, Md. : 1950). 2009; 182(4):2102-12. NIHMSID: NIHMS83466 PubMed [journal] PMID: 19201863, PMCID: PMC3682217 140. Bauquet AT, Jin H, Paterson AM, Mitsdoerffer M, Ho IC, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nature immunology. 2009; 10(2):167-75. NIHMSID: NIHMS79736 PubMed [journal] PMID: 19098919, PMCID: PMC2742982 141. Schmidt EM, Wang CJ, Ryan GA, Clough LE, Qureshi OS, et al. Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity. Journal of immunology (Baltimore, Md. : 1950). 2009; 182(1):274-82. PubMed [journal] PMID: 19109158 142. Chen L, Pai V, Levinson R, Sharpe AH, Freeman GJ, et al. Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis. Ocular immunology and inflammation. 2009; 17(1):47-55. PubMed [journal] PMID: 19294574 143. Brooks DG, Ha SJ, Elsaesser H, Sharpe AH, Freeman GJ, et al. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(51):20428-33. PubMed [journal] PMID: 19075244, PMCID: PMC2629263 144. Vogtenhuber C, O'Shaughnessy MJ, Vignali DA, Blazar BR. Outgrowth of CD4low/negCD25+ T cells with suppressor function in CD4+CD25+ T cell cultures upon polyclonal stimulation ex vivo. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(12):8767-75. NIHMSID: NIHMS104649 PubMed [journal] PMID: 19050298, PMCID: PMC2729660 145. Gotsman I, Sharpe AH, Lichtman AH. T-cell costimulation and coinhibition in atherosclerosis. Circulation research. 2008; 103(11):1220-31. NIHMSID: NIHMS88823 PubMed [journal] PMID: 19028921, PMCID: PMC2662382 146. Anderson A, Martens CL, Hendrix R, Stempora LL, Miller WP, et al. Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008; 8(11):2252-64. NIHMSID: NIHMS129682 PubMed [journal] PMID: 18801023, PMCID: PMC2874242 147. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(8):5396-404. NIHMSID: NIHMS81594 PubMed [journal] PMID: 18832696, PMCID: PMC2614675 148. Taylor PA, Ehrhardt MJ, Lees CJ, Panoskaltsis-Mortari A, Krieg AM, et al. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood. 2008; 112(8):3508-16. PubMed [journal] PMID: 18614760, PMCID: PMC2569186 149. Duan B, Niu H, Xu Z, Sharpe AH, Croker BP, et al. Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Laboratory investigation; a journal of technical methods and pathology. 2008; 88(9):1008-20. NIHMSID: NIHMS488629 PubMed [journal] PMID: 18607347, PMCID: PMC3731739 150. Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, et al. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(4):2513-21. NIHMSID: NIHMS54261 PubMed [journal] PMID: 18684942, PMCID: PMC2587295 151. Xiao S, Jin H, Korn T, Liu SM, Oukka M, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. Journal of immunology (Baltimore, Md. : 1950). 2008; 181(4):2277-84. NIHMSID: NIHMS79734 PubMed [journal] PMID: 18684916, PMCID: PMC2722959 152. Butte MJ, Peña-Cruz V, Kim MJ, Freeman GJ, Sharpe AH. Interaction of human PD-L1 and B7-1. Molecular immunology. 2008; 45(13):3567-72. NIHMSID: NIHMS63499 PubMed [journal] PMID: 18585785, PMCID: PMC3764616 153. Ha SJ, West EE, Araki K, Smith KA, Ahmed R. Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections. Immunological reviews. 2008; 223:317-33. PubMed [journal] PMID: 18613845 154. Akbari O, Stock P, Meyer EH, Freeman GJ, Sharpe AH, et al. ICOS/ICOSL interaction is required for CD4+ invariant NKT cell function and homeostatic survival. Journal of immunology (Baltimore, Md. : 1950). 2008; 180(8):5448-56. NIHMSID: NIHMS181857 PubMed [journal] PMID: 18390727, PMCID: PMC2835525 155. Ha SJ, Mueller SN, Wherry EJ, Barber DL, Aubert RD, et al. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. The Journal of experimental medicine. 2008; 205(3):543-55. PubMed [journal] PMID: 18332181, PMCID: PMC2275378 156. Cunninghame Graham DS, Vyse TJ, Fortin PR, Montpetit A, Cai YC, et al. Association of LY9 in UK and Canadian SLE families. Genes and immunity. 2008; 9(2):93-102. PubMed [journal] PMID: 18216865 157. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annual review of immunology. 2008; 26:677-704. PubMed [journal] PMID: 18173375 158. Kobayashi N, Karisola P, Peña-Cruz V, Dorfman DM, Jinushi M, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007; 27(6):927-40. NIHMSID: NIHMS36633 PubMed [journal] PMID: 18082433, PMCID: PMC2757006 159. Menke J, Lucas JA, Zeller GC, Keir ME, Huang XR, et al. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. Journal of immunology (Baltimore, Md. : 1950). 2007; 179(11):7466-77. PubMed [journal] PMID: 18025191 160. Grabie N, Gotsman I, DaCosta R, Pang H, Stavrakis G, et al. Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation. 2007; 116(18):2062-71. PubMed [journal] PMID: 17938288 161. Keir ME, Freeman GJ, Sharpe AH. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues. Journal of immunology (Baltimore, Md. : 1950). 2007; 179(8):5064-70. PubMed [journal] PMID: 17911591 162. Mueller SN, Matloubian M, Clemens DM, Sharpe AH, Freeman GJ, et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(39):15430-5. PubMed [journal] PMID: 17878315, PMCID: PMC2000533 163. Shen L, Jin Y, Freeman GJ, Sharpe AH, Dana MR. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. Journal of immunology (Baltimore, Md. : 1950). 2007; 179(6):3672-9. PubMed [journal] PMID: 17785803 164. Tai X, Van Laethem F, Sharpe AH, Singer A. Induction of autoimmune disease in CTLA-4-/- mice depends on a specific CD28 motif that is required for in vivo costimulation. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(34):13756-61. PubMed [journal] PMID: 17702861, PMCID: PMC1949493 165. Love VA, Grabie N, Duramad P, Stavrakis G, Sharpe A, et al. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes. Circulation research. 2007; 101(3):248-57. PubMed [journal] PMID: 17569889 166. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity. 2007; 27(1):111-22. NIHMSID: NIHMS27988 PubMed [journal] PMID: 17629517, PMCID: PMC2707944 167. Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity. Current opinion in immunology. 2007; 19(3):309-14. PubMed [journal] PMID: 17433872 168. Kwan KY, Greenwald RJ, Mohanty S, Sharpe AH, Shaw AC, et al. Development of autoimmunity in mice lacking DNA topoisomerase 3beta. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(22):9242-7. PubMed [journal] PMID: 17517607, PMCID: PMC1890479 169. Kim G, Levin M, Schoenberger SP, Sharpe A, Kronenberg M. Paradoxical effect of reduced costimulation in T cell-mediated colitis. Journal of immunology (Baltimore, Md. : 1950). 2007; 178(9):5563-70. PubMed [journal] PMID: 17442938 170. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nature immunology. 2007; 8(3):239-45. PubMed [journal] PMID: 17304234 171. Gotsman I, Grabie N, Gupta R, Dacosta R, MacConmara M, et al. Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation. 2006; 114(19):2047-55. PubMed [journal] PMID: 17060381 172. Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. The Journal of experimental medicine. 2006; 203(10):2223-7. PubMed [journal] PMID: 17000870, PMCID: PMC2118103 173. Read S, Greenwald R, Izcue A, Robinson N, Mandelbrot D, et al. Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. Journal of immunology (Baltimore, Md. : 1950). 2006; 177(7):4376-83. PubMed [journal] PMID: 16982872 174. Sharpe AH, Abbas AK. T-cell costimulation--biology, therapeutic potential, and challenges. The New England journal of medicine. 2006; 355(10):973-5. PubMed [journal] PMID: 16908487 175. Kim G, Schoenberger SP, Sharpe A, Kronenberg M. Synergistic costimulation by both B7 molecules regulates colitis pathogenesis. Annals of the New York Academy of Sciences. 2006; 1072:233-41. PubMed [journal] PMID: 17057203 176. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. The American journal of surgical pathology. 2006; 30(7):802-10. NIHMSID: NIHMS298194 PubMed [journal] PMID: 16819321, PMCID: PMC3137919 177. Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, et al. Tissue expression of PD-L1 mediates peripheral T cell tolerance. The Journal of experimental medicine. 2006; 203(4):883-95. PubMed [journal] PMID: 16606670, PMCID: PMC2118286 178. Lee KM, Forman JP, McNerney ME, Stepp S, Kuppireddi S, et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood. 2006; 107(8):3181-8. PubMed [journal] PMID: 15905190, PMCID: PMC1895752 179. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006; 439(7077):682-7. PubMed [journal] PMID: 16382236 180. Abadía-Molina AC, Ji H, Faubion WA, Julien A, Latchman Y, et al. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis. Gastroenterology. 2006; 130(2):424-34. PubMed [journal] PMID: 16472597 181. Liang SC, Greenwald RJ, Latchman YE, Rosas L, Satoskar A, et al. PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis. European journal of immunology. 2006; 36(1):58-64. PubMed [journal] PMID: 16358363 182. Zeller GC, Hirahashi J, Schwarting A, Sharpe AH, Kelley VR. Inducible co-stimulator null MRL-Faslpr mice: uncoupling of autoantibodies and T cell responses in lupus. Journal of the American Society of Nephrology : JASN. 2006; 17(1):122-30. PubMed [journal] PMID: 16291836 183. Miyamoto K, Kingsley CI, Zhang X, Jabs C, Izikson L, et al. The ICOS molecule plays a crucial role in the development of mucosal tolerance. Journal of immunology (Baltimore, Md. : 1950). 2005; 175(11):7341-7. PubMed [journal] PMID: 16301640 184. Keir ME, Latchman YE, Freeman GJ, Sharpe AH. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes. Journal of immunology (Baltimore, Md. : 1950). 2005; 175(11):7372-9. NIHMSID: NIHMS7036 PubMed [journal] PMID: 16301644, PMCID: PMC2779139 185. Ruiz-Perez B, Chung DR, Sharpe AH, Yagita H, Kalka-Moll WM, et al. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(46):16753-8. PubMed [journal] PMID: 16275921, PMCID: PMC1283807 186. Li L, Greenwald RJ, Lafuente EM, Tzachanis D, Berezovskaya A, et al. Rap1-GTP is a negative regulator of Th cell function and promotes the generation of CD4+CD103+ regulatory T cells in vivo. Journal of immunology (Baltimore, Md. : 1950). 2005; 175(5):3133-9. PubMed [journal] PMID: 16116203 187. van Berkel ME, Schrijver EH, Hofhuis FM, Sharpe AH, Coyle AJ, et al. ICOS contributes to T cell expansion in CTLA-4 deficient mice. Journal of immunology (Baltimore, Md. : 1950). 2005; 175(1):182-8. PubMed [journal] PMID: 15972646 188. Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, et al. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. Journal of immunology (Baltimore, Md. : 1950). 2005; 174(11):6648-56. PubMed [journal] PMID: 15905503 189. Loser K, Scherer A, Krummen MB, Varga G, Higuchi T, et al. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. Journal of immunology (Baltimore, Md. : 1950). 2005; 174(9):5298-305. PubMed [journal] PMID: 15843526 190. Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, Sharpe AH, Noelle RJ, et al. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood. 2005; 105(8):3372-80. PubMed [journal] PMID: 15618467 191. Keir ME, Sharpe AH. The B7/CD28 costimulatory family in autoimmunity. Immunological reviews. 2005; 204:128-43. PubMed [journal] PMID: 15790355 192. Sharpe A. Costimulation and regulation of autoimmunity and tolerance. Journal of pediatric gastroenterology and nutrition. 2005; 40 Suppl 1:S20-1. PubMed [journal] PMID: 15805834 193. Abbas AK, Sharpe AH. Dendritic cells giveth and taketh away. Nature immunology. 2005; 6(3):227-8. PubMed [journal] PMID: 15716967 194. Yamada A, Salama AD, Sho M, Najafian N, Ito T, et al. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. Journal of immunology (Baltimore, Md. : 1950). 2005; 174(3):1357-64. PubMed [journal] PMID: 15661893 195. Kang MS, Lu H, Yasui T, Sharpe A, Warren H, et al. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(3):820-5. PubMed [journal] PMID: 15640350, PMCID: PMC545574 196. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annual review of immunology. 2005; 23:515-48. PubMed [journal] PMID: 15771580 197. Ansel KM, Greenwald RJ, Agarwal S, Bassing CH, Monticelli S, et al. Deletion of a conserved Il4 silencer impairs T helper type 1-mediated immunity. Nature immunology. 2004; 5(12):1251-9. PubMed [journal] PMID: 15516924 198. Dawicki W, Bertram EM, Sharpe AH, Watts TH. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. Journal of immunology (Baltimore, Md. : 1950). 2004; 173(10):5944-51. PubMed [journal] PMID: 15528328 199. Kishimoto K, Yuan X, Auchincloss H Jr, Sharpe AH, Mandelbrot DA, et al. Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. Journal of the American Society of Nephrology : JASN. 2004; 15(9):2423-8. PubMed [journal] PMID: 15339991 200. Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, et al. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(29):10691-6. PubMed [journal] PMID: 15249675, PMCID: PMC489996 201. Wang N, Satoskar A, Faubion W, Howie D, Okamoto S, et al. The cell surface receptor SLAM controls T cell and macrophage functions. The Journal of experimental medicine. 2004; 199(9):1255-64. PubMed [journal] PMID: 15123745, PMCID: PMC2211908 202. Vijayakrishnan L, Slavik JM, Illés Z, Greenwald RJ, Rainbow D, et al. An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells. Immunity. 2004; 20(5):563-75. PubMed [journal] PMID: 15142525 203. Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. The Journal of clinical investigation. 2004; 113(10):1390-7. PubMed [journal] PMID: 15146236, PMCID: PMC406528 204. Buono C, Pang H, Uchida Y, Libby P, Sharpe AH, et al. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation. 2004; 109(16):2009-15. PubMed [journal] PMID: 15096453 205. Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, et al. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections]. Journal of immunology (Baltimore, Md. : 1950). 2004; 172(1):34-9. PubMed [journal] PMID: 14688306 206. Martin-Orozco N, Chen Z, Poirot L, Hyatt E, Chen A, et al. Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand. Journal of immunology (Baltimore, Md. : 1950). 2003; 171(12):6954-60. PubMed [journal] PMID: 14662903 207. Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, et al. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. Journal of immunology (Baltimore, Md. : 1950). 2003; 171(11):5673-7. PubMed [journal] PMID: 14634073 208. Rodig N, Ryan T, Allen JA, Pang H, Grabie N, et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. European journal of immunology. 2003; 33(11):3117-26. PubMed [journal] PMID: 14579280 209. Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, et al. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. European journal of immunology. 2003; 33(10):2706-16. PubMed [journal] PMID: 14515254 210. Ryeom S, Greenwald RJ, Sharpe AH, McKeon F. The threshold pattern of calcineurin-dependent gene expression is altered by loss of the endogenous inhibitor calcipressin. Nature immunology. 2003; 4(9):874-81. PubMed [journal] PMID: 12925851 211. Chang TT, Sobel RA, Wei T, Ransohoff RM, Kuchroo VK, et al. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice. European journal of immunology. 2003; 33(7):2022-2032. PubMed [journal] PMID: 12884869 212. Harada H, Salama AD, Sho M, Izawa A, Sandner SE, et al. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. The Journal of clinical investigation. 2003; 112(2):234-43. PubMed [journal] PMID: 12865411, PMCID: PMC164288 213. Lohr J, Knoechel B, Jiang S, Sharpe AH, Abbas AK. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nature immunology. 2003; 4(7):664-9. PubMed [journal] PMID: 12766766 214. Buhlmann JE, Elkin SK, Sharpe AH. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection. Journal of immunology (Baltimore, Md. : 1950). 2003; 170(11):5421-8. PubMed [journal] PMID: 12759417 215. Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, et al. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. Blood. 2003; 101(9):3741-8. PubMed [journal] PMID: 12521997 216. Ekkens MJ, Liu Z, Liu Q, Whitmire J, Xiao S, et al. The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus. Journal of immunology (Baltimore, Md. : 1950). 2003; 170(1):384-93. PubMed [journal] PMID: 12496423 217. Liu Z, Liu Q, Pesce J, Whitmire J, Ekkens MJ, et al. Nippostrongylus brasiliensis can induce B7-independent antigen-specific development of IL-4-producing T cells from naive CD4 T cells in vivo. Journal of immunology (Baltimore, Md. : 1950). 2002; 169(12):6959-68. PubMed [journal] PMID: 12471130 218. Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. Journal of immunology (Baltimore, Md. : 1950). 2002; 169(11):6298-308. PubMed [journal] PMID: 12444136 219. Green KA, Cook WJ, Sharpe AH, Green WR. The CD154/CD40 interaction required for retrovirus-induced murine immunodeficiency syndrome is not mediated by upregulation of the CD80/CD86 costimulatory molecules. Journal of virology. 2002; 76(24):13106-10. PubMed [journal] PMID: 12438641, PMCID: PMC136728 220. Prilliman KR, Lemmens EE, Palioungas G, Wolfe TG, Allison JP, et al. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL. Journal of immunology (Baltimore, Md. : 1950). 2002; 169(8):4094-7. PubMed [journal] PMID: 12370335 221. Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, et al. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. European journal of immunology. 2002; 32(10):2874-80. PubMed [journal] PMID: 12355440 222. Schneider H, Mandelbrot DA, Greenwald RJ, Ng F, Lechler R, et al. Cutting edge: CTLA-4 (CD152) differentially regulates mitogen-activated protein kinases (extracellular signal-regulated kinase and c-Jun N-terminal kinase) in CD4+ T cells from receptor/ligand-deficient mice. Journal of immunology (Baltimore, Md. : 1950). 2002; 169(7):3475-9. PubMed [journal] PMID: 12244135 223. Mencacci A, Montagnoli C, Bacci A, Cenci E, Pitzurra L, et al. CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis. Journal of immunology (Baltimore, Md. : 1950). 2002; 169(6):3180-90. PubMed [journal] PMID: 12218136 224. Jabs C, Greve B, Chang TT, Sobel RA, Sharpe AH, et al. Genetic background determines the requirement for B7 costimulation in induction of autoimmunity. European journal of immunology. 2002; 32(9):2687-97. PubMed [journal] PMID: 12207354 225. Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nature medicine. 2002; 8(9):1024-32. PubMed [journal] PMID: 12145647 226. Martin M, Sharpe A, Clements JD, Michalek SM. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli. Journal of immunology (Baltimore, Md. : 1950). 2002; 169(4):1744-52. PubMed [journal] PMID: 12165495 227. Freeman GJ, Sharpe AH, Kuchroo VK. Protect the killer: CTLs need defenses against the tumor. Nature medicine. 2002; 8(8):787-9. PubMed [journal] PMID: 12152031 228. Ekkens MJ, Liu Z, Liu Q, Foster A, Whitmire J, et al. Memory Th2 effector cells can develop in the absence of B7-1/B7-2, CD28 interactions, and effector Th cells after priming with an intestinal nematode parasite. Journal of immunology (Baltimore, Md. : 1950). 2002; 168(12):6344-51. PubMed [journal] PMID: 12055251 229. Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptors on lymphocytes. Current opinion in immunology. 2002; 14(3):391-6. PubMed [journal] PMID: 11973140 230. Brown JA, Greenwald RJ, Scott S, Schweitzer AN, Satoskar AR, et al. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major. European journal of immunology. 2002; 32(6):1764-72. PubMed [journal] PMID: 12115660 231. Greenwald RJ, Oosterwegel MA, van der Woude D, Kubal A, Mandelbrot DA, et al. CTLA-4 regulates cell cycle progression during a primary immune response. European journal of immunology. 2002; 32(2):366-73. PubMed [journal] PMID: 11807776 232. Greenwald RJ, McAdam AJ, Van der Woude D, Satoskar AR, Sharpe AH. Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. Journal of immunology (Baltimore, Md. : 1950). 2002; 168(3):991-5. PubMed [journal] PMID: 11801630 233. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nature reviews. Immunology. 2002; 2(2):116-26. PubMed [journal] PMID: 11910893 234. Chang TT, Kuchroo VK, Sharpe AH. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Current directions in autoimmunity. 2002; 5:113-30. PubMed [journal] PMID: 11826754 235. Mandelbrot DA, Kishimoto K, Auchincloss H Jr, Sharpe AH, Sayegh MH. Rejection of mouse cardiac allografts by costimulation in trans. Journal of immunology (Baltimore, Md. : 1950). 2001; 167(3):1174-8. PubMed [journal] PMID: 11466331 236. Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, et al. CD28-independent costimulation of T cells in alloimmune responses. Journal of immunology (Baltimore, Md. : 1950). 2001; 167(1):140-6. PubMed [journal] PMID: 11418642 237. Yoshida K, Kuo F, George EL, Sharpe AH, Dutta A. Requirement of CDC45 for postimplantation mouse development. Molecular and cellular biology. 2001; 21(14):4598-603. PubMed [journal] PMID: 11416137, PMCID: PMC87121 238. Wu C, Nguyen KB, Pien GC, Wang N, Gullo C, et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nature immunology. 2001; 2(5):410-4. PubMed [journal] PMID: 11323694 239. Mandelbrot DA, Oosterwegel MA, Shimizu K, Yamada A, Freeman GJ, et al. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4. The Journal of clinical investigation. 2001; 107(7):881-7. PubMed [journal] PMID: 11285307, PMCID: PMC199576 240. Witke W, Sutherland JD, Sharpe A, Arai M, Kwiatkowski DJ. Profilin I is essential for cell survival and cell division in early mouse development. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98(7):3832-6. PubMed [journal] PMID: 11274401, PMCID: PMC31138 241. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature immunology. 2001; 2(3):261-8. PubMed [journal] PMID: 11224527 242. Greenwald RJ, Boussiotis VA, Lorsbach RB, Abbas AK, Sharpe AH. CTLA-4 regulates induction of anergy in vivo. Immunity. 2001; 14(2):145-55. PubMed [journal] PMID: 11239447 243. McAdam AJ, Greenwald RJ, Levin MA, Chernova T, Malenkovich N, et al. ICOS is critical for CD40-mediated antibody class switching. Nature. 2001; 409(6816):102-5. PubMed [journal] PMID: 11343122 244. Santra S, Barouch DH, Jackson SS, Kuroda MJ, Schmitz JE, et al. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(12):6791-5. PubMed [journal] PMID: 11120800 245. Gaglia JL, Greenfield EA, Mattoo A, Sharpe AH, Freeman GJ, et al. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(11):6091-8. PubMed [journal] PMID: 11086041 246. McAdam AJ, Chang TT, Lumelsky AE, Greenfield EA, Boussiotis VA, et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(9):5035-40. PubMed [journal] PMID: 11046032 247. Liang B, Kashgarian MJ, Sharpe AH, Mamula MJ. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(6):3436-43. PubMed [journal] PMID: 10975864 248. McAdam AJ, Gewurz BE, Farkash EA, Sharpe AH. Either B7 costimulation or IL-2 can elicit generation of primary alloreactive CTL. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(6):3088-93. PubMed [journal] PMID: 10975820 249. Santra S, Barouch DH, Sharpe AH, Letvin NL. B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination. European journal of immunology. 2000; 30(9):2650-9. PubMed [journal] PMID: 11009099 250. Furukawa Y, Mandelbrot DA, Libby P, Sharpe AH, Mitchell RN. Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. The American journal of pathology. 2000; 157(2):473-84. PubMed [journal] PMID: 10934151, PMCID: PMC1850132 251. Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular and cellular biology. 2000; 20(15):5479-89. PubMed [journal] PMID: 10891488, PMCID: PMC85999 252. Kasprowicz DJ, Kohm AP, Berton MT, Chruscinski AJ, Sharpe A, et al. Stimulation of the B cell receptor, CD86 (B7-2), and the beta 2-adrenergic receptor intrinsically modulates the level of IgG1 and IgE produced per B cell. Journal of immunology (Baltimore, Md. : 1950). 2000; 165(2):680-90. PubMed [journal] PMID: 10878340 253. Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, et al. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. Journal of immunology (Baltimore, Md. : 1950). 2000; 164(11):6046-56. PubMed [journal] PMID: 10820290 254. Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Molecular and cellular biology. 2000; 20(9):3286-91. PubMed [journal] PMID: 10757812, PMCID: PMC85622 255. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity. 2000; 12(4):431-40. PubMed [journal] PMID: 10795741 256. Yu X, Fournier S, Allison JP, Sharpe AH, Hodes RJ. The role of B7 costimulation in CD4/CD8 T cell homeostasis. Journal of immunology (Baltimore, Md. : 1950). 2000; 164(7):3543-53. PubMed [journal] PMID: 10725709 257. Szot GL, Zhou P, Sharpe AH, He G, Kim O, et al. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000; 69(5):904-9. PubMed [journal] PMID: 10755548 258. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 2000; 404(6773):99-103. PubMed [journal] PMID: 10716451 259. Mark DA, Donovan CE, De Sanctis GT, He HZ, Cernadas M, et al. B7-1 (CD80) and B7-2 (CD86) have complementary roles in mediating allergic pulmonary inflammation and airway hyperresponsiveness. American journal of respiratory cell and molecular biology. 2000; 22(3):265-71. PubMed [journal] PMID: 10696062 260. Qian J, Collins M, Sharpe AH, Hoyer LW. Prevention and treatment of factor VIII inhibitors in murine hemophilia A. Blood. 2000; 95(4):1324-9. PubMed [journal] PMID: 10666206 261. Lynch WP, Sharpe AH. Differential glycosylation of the Cas-Br-E env protein is associated with retrovirus-induced spongiform neurodegeneration. Journal of virology. 2000; 74(3):1558-65. PubMed [journal] PMID: 10627570, PMCID: PMC111494 262. Girvin AM, Dal Canto MC, Rhee L, Salomon B, Sharpe A, et al. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. Journal of immunology (Baltimore, Md. : 1950). 2000; 164(1):136-43. PubMed [journal] PMID: 10605004 263. McAdam AJ, Farkash EA, Gewurz BE, Sharpe AH. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. Journal of virology. 2000; 74(1):203-8. PubMed [journal] PMID: 10590107, PMCID: PMC111529 264. Anderson DE, Sharpe AH, Hafler DA. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system. Current opinion in immunology. 1999; 11(6):677-83. PubMed [journal] PMID: 10631554 265. Chen AI, McAdam AJ, Buhlmann JE, Scott S, Lupher ML Jr, et al. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. Immunity. 1999; 11(6):689-98. PubMed [journal] PMID: 10626891 266. Guttormsen HK, Sharpe AH, Chandraker AK, Brigtsen AK, Sayegh MH, et al. Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infection and immunity. 1999; 67(12):6375-84. PubMed [journal] PMID: 10569753, PMCID: PMC97045 267. Abbas AK, Sharpe AH. T-cell stimulation: an abundance of B7s. Nature medicine. 1999; 5(12):1345-6. PubMed [journal] PMID: 10581066 268. Schweitzer AN, Sharpe AH. Mutual regulation between B7-1 (CD80) expressed on T cells and IL-4. Journal of immunology (Baltimore, Md. : 1950). 1999; 163(9):4819-25. PubMed [journal] PMID: 10528182 269. Mandelbrot DA, Furukawa Y, McAdam AJ, Alexander SI, Libby P, et al. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. Journal of immunology (Baltimore, Md. : 1950). 1999; 163(7):3753-7. PubMed [journal] PMID: 10490971 270. Ling V, Wu PW, Finnerty HF, Sharpe AH, Gray GS, et al. Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders. Genomics. 1999; 60(3):341-55. PubMed [journal] PMID: 10493833 271. Chang TT, Jabs C, Sobel RA, Kuchroo VK, Sharpe AH. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. The Journal of experimental medicine. 1999; 190(5):733-40. PubMed [journal] PMID: 10477557, PMCID: PMC2195617 272. Oosterwegel MA, Mandelbrot DA, Boyd SD, Lorsbach RB, Jarrett DY, et al. The role of CTLA-4 in regulating Th2 differentiation. Journal of immunology (Baltimore, Md. : 1950). 1999; 163(5):2634-9. PubMed [journal] PMID: 10453003 273. Humphries DE, Wong GW, Friend DS, Gurish MF, Qiu WT, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature. 1999; 400(6746):769-72. PubMed [journal] PMID: 10466726 274. Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Journal of immunology (Baltimore, Md. : 1950). 1999; 163(4):2322-9. PubMed [journal] PMID: 10438978 275. Lynch WP, Sharpe AH, Snyder EY. Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. Journal of virology. 1999; 73(8):6841-51. PubMed [journal] PMID: 10400782, PMCID: PMC112769 276. Oosterwegel MA, Greenwald RJ, Mandelbrot DA, Lorsbach RB, Sharpe AH. CTLA-4 and T cell activation. Current opinion in immunology. 1999; 11(3):294-300. PubMed [journal] PMID: 10375557 277. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells. Journal of immunology (Baltimore, Md. : 1950). 1999; 162(11):6368-77. PubMed [journal] PMID: 10352249 278. Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. Journal of immunology (Baltimore, Md. : 1950). 1999; 162(10):5784-91. PubMed [journal] PMID: 10229811 279. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999; 398(6729):714-8. PubMed [journal] PMID: 10227294 280. La Motte RN, Sharpe AH, Bluestone JA, Mokyr MB. Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism. Journal of immunology (Baltimore, Md. : 1950). 1999; 162(8):4817-23. PubMed [journal] PMID: 10202025 281. Greenwald RJ, Urban JF, Ekkens MJ, Chen S, Nguyen D, et al. B7-2 is required for the progression but not the initiation of the type 2 immune response to a gastrointestinal nematode parasite. Journal of immunology (Baltimore, Md. : 1950). 1999; 162(7):4133-9. PubMed [journal] PMID: 10201938 282. Hernandez HJ, Sharpe AH, Stadecker MJ. Experimental murine schistosomiasis in the absence of B7 costimulatory molecules: reversal of elicited T cell cytokine profile and partial inhibition of egg granuloma formation. Journal of immunology (Baltimore, Md. : 1950). 1999; 162(5):2884-9. PubMed [journal] PMID: 10072537 283. Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, et al. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. Journal of immunology (Baltimore, Md. : 1950). 1999; 162(4):1947-51. PubMed [journal] PMID: 9973463 284. González-Cabrero J, Wise CJ, Latchman Y, Freeman GJ, Sharpe AH, et al. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 1999; 96(3):1019-23. PubMed [journal] PMID: 9927686, PMCID: PMC15343 285. Mandelbrot DA, McAdam AJ, Sharpe AH. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). The Journal of experimental medicine. 1999; 189(2):435-40. PubMed [journal] PMID: 9892625, PMCID: PMC2192978 286. La Motte RN, Sharpe AH, Bluestone JA, Mokyr MB. Importance of B7-1-expressing host antigen-presenting cells for the eradication of B7-2 transfected P815 tumor cells. Journal of immunology (Baltimore, Md. : 1950). 1998; 161(12):6552-8. PubMed [journal] PMID: 9862681 287. Rauschmayr-Kopp T, Williams IR, Borriello F, Sharpe AH, Kupper TS. Distinct roles for B7 costimulation in contact hypersensitivity and humoral immune responses to epicutaneous antigen. European journal of immunology. 1998; 28(12):4221-7. PubMed [journal] PMID: 9862359 288. Wang B, Wang N, Salio M, Sharpe A, Allen D, et al. Essential and partially overlapping role of CD3gamma and CD3delta for development of alphabeta and gammadelta T lymphocytes. The Journal of experimental medicine. 1998; 188(7):1375-80. PubMed [journal] PMID: 9763617, PMCID: PMC2212484 289. McAdam AJ, Schweitzer AN, Sharpe AH. The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunological reviews. 1998; 165:231-47. PubMed [journal] PMID: 9850864 290. Schweitzer AN, Sharpe AH. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. Journal of immunology (Baltimore, Md. : 1950). 1998; 161(6):2762-71. PubMed [journal] PMID: 9743334 291. Schweitzer AN, Sharpe AH. The complexity of the B7-CD28/CTLA-4 costimulatory pathway. Agents and actions. Supplements. 1998; 49:33-43. PubMed [journal] PMID: 9426826 292. Van Parijs L, Sethna MP, Schweitzer AN, Borriello F, Sharpe AH, et al. Functional consequences of dysregulated B7-1 (CD80) and B7-2 (CD86) expression in B or T lymphocytes of transgenic mice. Journal of immunology (Baltimore, Md. : 1950). 1997; 159(11):5336-44. PubMed [journal] PMID: 9548473 293. Zheng XX, Sayegh MH, Zheng XG, Li Y, Linsley PS, et al. The role of donor and recipient B7-1 (CD80) in allograft rejection. Journal of immunology (Baltimore, Md. : 1950). 1997; 159(3):1169-73. PubMed [journal] PMID: 9233610 294. Reeves RH, Patch D, Sharpe AH, Borriello F, Freeman GJ, et al. The costimulatory genes Cd80 and Cd86 are linked on mouse chromosome 16 and human chromosome 3. Mammalian genome : official journal of the International Mammalian Genome Society. 1997; 8(8):581-2. PubMed [journal] PMID: 9250865 295. Tivol EA, Boyd SD, McKeon S, Borriello F, Nickerson P, et al. CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. Journal of immunology (Baltimore, Md. : 1950). 1997; 158(11):5091-4. PubMed [journal] PMID: 9164923 296. Borriello F, Lederer J, Scott S, Sharpe AH. MRC OX-2 defines a novel T cell costimulatory pathway. Journal of immunology (Baltimore, Md. : 1950). 1997; 158(10):4548-54. PubMed [journal] PMID: 9144466 297. Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. Journal of immunology (Baltimore, Md. : 1950). 1997; 158(6):2713-22. PubMed [journal] PMID: 9058805 298. Borriello F, Sethna MP, Boyd SD, Schweitzer AN, Tivol EA, et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity. 1997; 6(3):303-13. PubMed [journal] PMID: 9075931 299. Greenfield EA, Howard E, Paradis T, Nguyen K, Benazzo F, et al. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors. Journal of immunology (Baltimore, Md. : 1950). 1997; 158(5):2025-34. PubMed [journal] PMID: 9036945 300. Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, et al. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature genetics. 1997; 15(3):303-6. PubMed [journal] PMID: 9054947 301. Tivol EA, Schweitzer AN, Sharpe AH. Costimulation and autoimmunity. Current opinion in immunology. 1996; 8(6):822-30. PubMed [journal] PMID: 8994862 302. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, et al. A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. 1996; 5(6):653-66. PubMed [journal] PMID: 8986723 303. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 1996; 5(6):537-49. PubMed [journal] PMID: 8986714 304. Lynch WP, Snyder EY, Qualtiere L, Portis JL, Sharpe AH. Late virus replication events in microglia are required for neurovirulent retrovirus-induced spongiform neurodegeneration: evidence from neural progenitor-derived chimeric mouse brains. Journal of virology. 1996; 70(12):8896-907. PubMed [journal] PMID: 8971019, PMCID: PMC190987 305. Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell. 1996; 87(4):697-708. PubMed [journal] PMID: 8929538 306. Blazar BR, Sharpe AH, Taylor PA, Panoskaltsis-Mortari A, Gray GS, et al. Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. Journal of immunology (Baltimore, Md. : 1950). 1996; 157(8):3250-9. PubMed [journal] PMID: 8871619 307. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(8):3444-9. PubMed [journal] PMID: 8622955, PMCID: PMC39628 308. Borriello F, Oliveros J, Freeman GJ, Nadler LM, Sharpe AH. Differential expression of alternate mB7-2 transcripts. Journal of immunology (Baltimore, Md. : 1950). 1995; 155(12):5490-7. PubMed [journal] PMID: 7499829 309. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science (New York, N.Y.). 1995; 270(5237):794-7. PubMed [journal] PMID: 7481767 310. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity. 1995; 3(5):541-7. PubMed [journal] PMID: 7584144 311. Sharpe AH. Analysis of lymphocyte costimulation in vivo using transgenic and 'knockout' mice. Current opinion in immunology. 1995; 7(3):389-95. PubMed [journal] PMID: 7546405 312. Perkins AC, Sharpe AH, Orkin SH. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature. 1995; 375(6529):318-22. PubMed [journal] PMID: 7753195 313. Johnson KA, Lerner CP, Di Lacio LC, Laird PW, Sharpe AH, et al. Transgenic mice for the preparation of hygromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selections. Nucleic acids research. 1995; 23(7):1273-5. PubMed [journal] PMID: 7739908, PMCID: PMC306843 314. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP, et al. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell. 1995; 81(1):41-51. PubMed [journal] PMID: 7720072 315. Prabhu Das MR, Zamvil SS, Borriello F, Weiner HL, Sharpe AH, et al. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. European journal of immunology. 1995; 25(1):207-11. PubMed [journal] PMID: 7531145 316. Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, et al. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes & development. 1995; 9(1):1-14. PubMed [journal] PMID: 7530222 317. Jellis CL, Wang SS, Rennert P, Borriello F, Sharpe AH, et al. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86). Immunogenetics. 1995; 42(2):85-9. PubMed [journal] PMID: 7541777 318. Borriello F, Freeman GJ, Edelhoff S, Disteche CM, Nadler LM, et al. Characterization of the murine B7-1 genomic locus reveals an additional exon encoding an alternative cytoplasmic domain and a chromosomal location of chromosome 16, band B5. Journal of immunology (Baltimore, Md. : 1950). 1994; 153(11):5038-48. PubMed [journal] PMID: 7525722 319. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994; 79(1):143-56. PubMed [journal] PMID: 7923373 320. Sethna MP, van Parijs L, Sharpe AH, Abbas AK, Freeman GJ. A negative regulatory function of B7 revealed in B7-1 transgenic mice. Immunity. 1994; 1(5):415-21. PubMed [journal] PMID: 7533646 321. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Gribben JG, et al. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. The Journal of experimental medicine. 1993; 178(6):2185-92. PubMed [journal] PMID: 7504059, PMCID: PMC2191273 322. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Hathcock KS, et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (New York, N.Y.). 1993; 262(5135):907-9. PubMed [journal] PMID: 7694362 323. Sharpe AH, Jaenisch R. Retroviral spongiform degenerative disease produced by the murine neurotropic retrovirus Cas-Br-E. Developments in biological standardization. 1993; 80:45-52. PubMed [journal] PMID: 8270115 324. Lee KF, Li E, Huber LJ, Landis SC, Sharpe AH, et al. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell. 1992; 69(5):737-49. PubMed [journal] PMID: 1317267 325. Huszar D, Sharpe A, Hashmi S, Bouchard B, Houghton A, et al. Generation of pigmented stripes in albino mice by retroviral marking of neural crest melanoblasts. Development (Cambridge, England). 1991; 113(2):653-60. PubMed [journal] PMID: 1782871 326. Huszar D, Sharpe A, Jaenisch R. Migration and proliferation of cultured neural crest cells in W mutant neural crest chimeras. Development (Cambridge, England). 1991; 112(1):131-41. PubMed [journal] PMID: 1769323 327. Lee JS, Mullaney S, Bronson R, Sharpe AH, Jaenisch R, et al. Transplacental antiretroviral therapy with 9-(2-phosphonylmethoxyethyl)adenine is embryotoxic in transgenic mice. Journal of acquired immune deficiency syndromes. 1991; 4(9):833-8. PubMed [journal] PMID: 1895203 328. Weiher H, Noda T, Gray DA, Sharpe AH, Jaenisch R. Transgenic mouse model of kidney disease: insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell. 1990; 62(3):425-34. PubMed [journal] PMID: 1696177 329. Sharpe AH, Hunter JJ, Chassler P, Jaenisch R. Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature. 1990; 346(6280):181-3. PubMed [journal] PMID: 2195355 330. Ruprecht RM, Sharpe AH, Jaenisch R, Trites D. Analysis of 3'-azido-3'-deoxythymidine levels in tissues and milk by isocratic high-performance liquid chromatography. Journal of chromatography. 1990; 528(2):371-83. PubMed [journal] PMID: 2384575 331. Wu H, Bateman JF, Schnieke A, Sharpe A, Barker D, et al. Human-mouse interspecies collagen I heterotrimer is functional during embryonic development of Mov13 mutant mouse embryos. Molecular and cellular biology. 1990; 10(4):1452-60. PubMed [journal] PMID: 1690840, PMCID: PMC362247 332. Sugimoto M, Sharpe AH, Sato Y, Greene MI, Fields BN. Reovirus transport--studies using lymphocytosis promoting factor. Pathobiology : journal of immunopathology, molecular and cellular biology. 1990; 58(4):185-92. PubMed [journal] PMID: 2174674 333. Compere SJ, Baldacci P, Sharpe AH, Thompson T, Land H, et al. The ras and myc oncogenes cooperate in tumor induction in many tissues when introduced into midgestation mouse embryos by retroviral vectors. Proceedings of the National Academy of Sciences of the United States of America. 1989; 86(7):2224-8. PubMed [journal] PMID: 2648394, PMCID: PMC286884 334. Sharpe AH, Hunter JJ, Ruprecht RM, Jaenisch R. Maternal transmission of retroviral disease and strategies for preventing infection of the neonate. Journal of virology. 1989; 63(3):1049-53. PubMed [journal] PMID: 2915376, PMCID: PMC247797 335. Compere SJ, Baldacci PA, Sharpe AH, Jaenisch R. Retroviral transduction of the human c-Ha-ras-1 oncogene into midgestation mouse embryos promotes rapid epithelial hyperplasia. Molecular and cellular biology. 1989; 9(1):6-14. PubMed [journal] PMID: 2648134, PMCID: PMC362139 336. Sharpe AH, Hunter JJ, Ruprecht RM, Jaenisch R. Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America. 1988; 85(24):9792-6. PubMed [journal] PMID: 2849117, PMCID: PMC282867 337. Sharpe AH, Jaenisch R, Ruprecht RM. Retroviruses and mouse embryos: a rapid model for neurovirulence and transplacental antiviral therapy. Science (New York, N.Y.). 1987; 236(4809):1671-4. PubMed [journal] PMID: 3037694 338. Wolf JL, Dambrauskas R, Sharpe AH, Trier JS. Adherence to and penetration of the intestinal epithelium by reovirus type 1 in neonatal mice. Gastroenterology. 1987; 92(1):82-91. PubMed [journal] PMID: 3023169 339. Gaulton GN, Sharpe AH, Chang DW, Fields BN, Greene MI. Syngeneic monoclonal internal image anti-idiotopes as prophylactic vaccines. Journal of immunology (Baltimore, Md. : 1950). 1986; 137(9):2930-6. PubMed [journal] PMID: 3020129 340. Sharpe AH, Gaulton GN, Ertl HC, Finberg RW, McDade KK, et al. Cell receptors for the mammalian reovirus. IV. Reovirus-specific cytolytic T cell lines that have idiotypic receptors recognize anti-idiotypic B cell hybridomas. Journal of immunology (Baltimore, Md. : 1950). 1985; 134(4):2702-6. PubMed [journal] PMID: 2579153 341. Sharpe AH, Fields BN. Pathogenesis of viral infections. Basic concepts derived from the reovirus model. The New England journal of medicine. 1985; 312(8):486-97. PubMed [journal] PMID: 2982096 342. Sharpe AH, Gaulton GN, McDade KK, Fields BN, Greene MI. Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. The Journal of experimental medicine. 1984; 160(4):1195-205. PubMed [journal] PMID: 6332875, PMCID: PMC2187481 343. Sharpe AH, Fields BN. Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology. 1982; 122(2):381-91. PubMed [journal] PMID: 6183822 344. Sharpe AH, Chen LB, Fields BN. The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology. 1982; 120(2):399-411. PubMed [journal] PMID: 7201720 345. Ahmed R, Canning WM, Kauffman RS, Sharpe AH, Hallum JV, et al. Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell. 1981; 25(2):325-32. PubMed [journal] PMID: 7285112 346. Wolf JL, Rubin DH, Finberg R, Kauffman RS, Sharpe AH, et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science (New York, N.Y.). 1981; 212(4493):471-2. PubMed [journal] PMID: 6259737 347. Sharpe AH, Fields BN. Reovirus inhibition of cellular DNA synthesis: role of the S1 gene. Journal of virology. 1981; 38(1):389-92. PubMed [journal] PMID: 7241660, PMCID: PMC171164 348. Sharpe AH, Chen LB, Murphy JR, Fields BN. Specific disruption of vimentin filament organization in monkey kidney CV-1 cells by diphtheria toxin, exotoxin A, and cycloheximide. Proceedings of the National Academy of Sciences of the United States of America. 1980; 77(12):7267-71. PubMed [journal] PMID: 6784120, PMCID: PMC350483 349. Fields BN, Weiner HL, Drayna DT, Sharpe AH. The role of the reovirus hemagglutinin in viral virulence. Annals of the New York Academy of Sciences. 1980; 354:125-34. PubMed [journal] PMID: 7013619 350. Mustoe TA, Ramig RF, Sharpe AH, Fields BN. Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes. Virology. 1978; 89(2):594-604. PubMed [journal] PMID: 716219 351. Mustoe TA, Ramig RF, Sharpe AH, Fields BN. A genetic map of reovirus. III. Assignment of the double-stranded RNA-positive mutant groups A, B, and G to genome segments. Virology. 1978; 85(2):545-56. PubMed [journal] PMID: 664215 352. Ramig RF, Mustoe TA, Sharpe AH, Fields BN. A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments. Virology. 1978; 85(2):531-4. PubMed [journal] PMID: 664214 353. Sharpe AH, Ramig RF, Mustoe TA, Fields BN. A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3. Virology. 1978; 84(1):63-74. PubMed [journal] PMID: 619493 354. Sharpe A, Blumberg PM, Strominger JL. D-alanine carboxypeptidase and cell wall cross-linking in Bacillus subtilis. Journal of bacteriology. 1974; 117(2):926-7. PubMed [journal] PMID: 4204447, PMCID: PMC285596 355. The role of reovirus hemagglutinin in virulence Fields BN, Weiner HL, Raig RF, Ray U, Drayna DT, et al. Munich Symposia on Mircobiology. Mechanisms of Viral Pathogenesis and Virulence. . WHO Collaborating Centre for Collection and Evaluation of Data on Comparative Virology; 1979; , Germany. c 00 . My Bibliography [meeting] 356. Dendritic cells but not lymph node stroma initiate ileitis by expanding T cells with gut-homing specificity upon PD-L1 blockade1 Journal of immunology (Baltimore, Md. : 1950). My Bibliography [journal]